Stay updated on AMG 133 Dose-ranging in Overweight Adults Clinical Trial
Sign up to get notified when there's something new on the AMG 133 Dose-ranging in Overweight Adults Clinical Trial page.

Latest updates to the AMG 133 Dose-ranging in Overweight Adults Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a detailed study on obesity and Type 2 diabetes, including its methodology and inclusion/exclusion criteria. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference9%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 20, 2025.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 20, 2025, and version 2.14.2.SummaryDifference0.2%
- Check66 days agoChange DetectedThe page has been updated with new certification and extension dates, specifically for submissions and postings in February 2025, while some previous dates and a notice about service performance have been removed.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to AMG 133 Dose-ranging in Overweight Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMG 133 Dose-ranging in Overweight Adults Clinical Trial page.